Cargando…

Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity

Monoclonal antibodies (mAbs) are widely used and powerful research tools, but the generation of mAbs against glycan epitopes is generally more problematic than against proteins. This is especially significant for research on polysaccharide-rich land plants and algae (Viridiplantae). Most antibody pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rydahl, Maja G., Kračun, Stjepan K., Fangel, Jonatan U., Michel, Gurvan, Guillouzo, Alexia, Génicot, Sabine, Mravec, Jozef, Harholt, Jesper, Wilkens, Casper, Motawia, Mohammed Saddik, Svensson, Birte, Tranquet, Olivier, Ralet, Marie-Christine, Jørgensen, Bodil, Domozych, David S., Willats, William G. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570955/
https://www.ncbi.nlm.nih.gov/pubmed/28839196
http://dx.doi.org/10.1038/s41598-017-04307-2
_version_ 1783259256138498048
author Rydahl, Maja G.
Kračun, Stjepan K.
Fangel, Jonatan U.
Michel, Gurvan
Guillouzo, Alexia
Génicot, Sabine
Mravec, Jozef
Harholt, Jesper
Wilkens, Casper
Motawia, Mohammed Saddik
Svensson, Birte
Tranquet, Olivier
Ralet, Marie-Christine
Jørgensen, Bodil
Domozych, David S.
Willats, William G. T.
author_facet Rydahl, Maja G.
Kračun, Stjepan K.
Fangel, Jonatan U.
Michel, Gurvan
Guillouzo, Alexia
Génicot, Sabine
Mravec, Jozef
Harholt, Jesper
Wilkens, Casper
Motawia, Mohammed Saddik
Svensson, Birte
Tranquet, Olivier
Ralet, Marie-Christine
Jørgensen, Bodil
Domozych, David S.
Willats, William G. T.
author_sort Rydahl, Maja G.
collection PubMed
description Monoclonal antibodies (mAbs) are widely used and powerful research tools, but the generation of mAbs against glycan epitopes is generally more problematic than against proteins. This is especially significant for research on polysaccharide-rich land plants and algae (Viridiplantae). Most antibody production is based on using single antigens, however, there are significant gaps in the current repertoire of mAbs against some glycan targets with low immunogenicity. We approached mAb production in a different way and immunised with a complex mixture of polysaccharides. The multiplexed screening capability of carbohydrate microarrays was then exploited to deconvolute the specificities of individual mAbs. Using this strategy, we generated a set of novel mAbs, including one against starch (INCh1) and one against ulvan (INCh2). These polysaccharides are important storage and structural polymers respectively, but both are generally considered as having limited immunogenicity. INCh1 and INCh2 therefore represent important new molecular probes for Viridiplantae research. Moreover, since the α-(1-4)-glucan epitope recognised by INCh1 is also a component of glycogen, this mAb can also be used in mammalian systems. We describe the detailed characterisation of INCh1 and INCh2, and discuss the potential of a non-directed mass-screening approach for mAb production against some glycan targets.
format Online
Article
Text
id pubmed-5570955
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55709552017-09-01 Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity Rydahl, Maja G. Kračun, Stjepan K. Fangel, Jonatan U. Michel, Gurvan Guillouzo, Alexia Génicot, Sabine Mravec, Jozef Harholt, Jesper Wilkens, Casper Motawia, Mohammed Saddik Svensson, Birte Tranquet, Olivier Ralet, Marie-Christine Jørgensen, Bodil Domozych, David S. Willats, William G. T. Sci Rep Article Monoclonal antibodies (mAbs) are widely used and powerful research tools, but the generation of mAbs against glycan epitopes is generally more problematic than against proteins. This is especially significant for research on polysaccharide-rich land plants and algae (Viridiplantae). Most antibody production is based on using single antigens, however, there are significant gaps in the current repertoire of mAbs against some glycan targets with low immunogenicity. We approached mAb production in a different way and immunised with a complex mixture of polysaccharides. The multiplexed screening capability of carbohydrate microarrays was then exploited to deconvolute the specificities of individual mAbs. Using this strategy, we generated a set of novel mAbs, including one against starch (INCh1) and one against ulvan (INCh2). These polysaccharides are important storage and structural polymers respectively, but both are generally considered as having limited immunogenicity. INCh1 and INCh2 therefore represent important new molecular probes for Viridiplantae research. Moreover, since the α-(1-4)-glucan epitope recognised by INCh1 is also a component of glycogen, this mAb can also be used in mammalian systems. We describe the detailed characterisation of INCh1 and INCh2, and discuss the potential of a non-directed mass-screening approach for mAb production against some glycan targets. Nature Publishing Group UK 2017-08-24 /pmc/articles/PMC5570955/ /pubmed/28839196 http://dx.doi.org/10.1038/s41598-017-04307-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Rydahl, Maja G.
Kračun, Stjepan K.
Fangel, Jonatan U.
Michel, Gurvan
Guillouzo, Alexia
Génicot, Sabine
Mravec, Jozef
Harholt, Jesper
Wilkens, Casper
Motawia, Mohammed Saddik
Svensson, Birte
Tranquet, Olivier
Ralet, Marie-Christine
Jørgensen, Bodil
Domozych, David S.
Willats, William G. T.
Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity
title Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity
title_full Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity
title_fullStr Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity
title_full_unstemmed Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity
title_short Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity
title_sort development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570955/
https://www.ncbi.nlm.nih.gov/pubmed/28839196
http://dx.doi.org/10.1038/s41598-017-04307-2
work_keys_str_mv AT rydahlmajag developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT kracunstjepank developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT fangeljonatanu developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT michelgurvan developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT guillouzoalexia developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT genicotsabine developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT mravecjozef developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT harholtjesper developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT wilkenscasper developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT motawiamohammedsaddik developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT svenssonbirte developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT tranquetolivier developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT raletmariechristine developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT jørgensenbodil developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT domozychdavids developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity
AT willatswilliamgt developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity